Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antibiotic Management of Lung Infections in Cystic Fibrosis. II. Nontuberculous Mycobacteria, Anaerobic Bacteria, and Fungi.
[allergic bronchopulmonary aspergillosis]
Airway
infections
are
a
key
component
of
cystic
fibrosis
(
CF
)
lung
disease
.
Whereas
the
approach
to
common
pathogens
such
as
Pseudomonas
aeruginosa
is
guided
by
a
significant
body
of
evidence
,
other
infections
often
pose
a
considerable
challenge
to
treating
physicians
.
In
Part
I
of
this
series
on
the
antibiotic
management
of
difficult
lung
infections
,
we
discussed
bacterial
organisms
including
methicillin-resistant
Staphylococcus
aureus
,
gram-negative
bacterial
infections
,
and
treatment
of
multiple
bacterial
pathogens
.
Here
,
we
summarize
the
approach
to
infections
with
nontuberculous
mycobacteria
,
anaerobic
bacteria
,
and
fungi
.
Nontuberculous
mycobacteria
can
significantly
impact
the
course
of
lung
disease
in
patients
with
CF
,
but
differentiation
between
colonization
and
infection
is
difficult
clinically
as
coinfection
with
other
micro-organisms
is
common
.
Treatment
consists
of
different
classes
of
antibiotics
,
varies
in
intensity
,
and
is
best
guided
by
a
team
of
specialized
clinicians
and
microbiologists
.
The
ability
of
anaerobic
bacteria
to
contribute
to
CF
lung
disease
is
less
clear
,
even
though
clinical
relevance
has
been
reported
in
individual
patients
.
Anaerobes
detected
in
CF
sputum
are
often
resistant
to
multiple
drugs
,
and
treatment
has
not
yet
been
shown
to
positively
affect
patient
outcome
.
Fungi
have
gained
significant
interest
as
potential
CF
pathogens
.
Although
the
role
of
Candida
is
largely
unclear
,
there
is
mounting
evidence
that
Scedosporium
species
and
Aspergillus
fumigatus
,
beyond
the
classical
presentation
of
allergic
bronchopulmonary
aspergillosis
,
can
be
relevant
in
patients
with
CF
and
treatment
should
be
considered
.
At
present
,
however
there
remains
limited
information
on
how
best
to
select
patients
who
could
benefit
from
antifungal
therapy
.
Diseases
Validation
Diseases presenting
"limited information on how best to select patients"
symptom
allergic bronchopulmonary aspergillosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom